Advertisement
Journal Home
Search for

Volume 10, Issue 3, Pages 105-109 (September 2009)


View previous. 5 of 12 View next.

Exercise and physical activity in children with cystic fibrosis

Donna L. Wilkes1, Jane E. Schneiderman1, Thanh Nguyen1, Liane Heale1, Fiona Moola4, Felix Ratjen1, Allan L. Coates1, Greg D. Wells23Corresponding Author Informationemail address

Summary 

Regular exercise and habitual physical activity are important for patients with cystic fibrosis (CF). Research has demonstrated the benefits of aerobic, anaerobic, and strength exercise training programs for health and quality of life, however, the CF patient is faced with unique barriers and challenges to participation. Recently, increased levels of habitual physical activity have been shown to slow the decline in lung function in patients with CF, and regular participation in a variety of activities may result in greater adherence in the long term. Research is now available to justify the incorporation of exercise into the routine care of patients with CF. This paper provides the background and rationale for the implementation of exercise and habitual physical activity recommendations by the health care team. Education of health care providers regarding the importance of exercise and habitual physical activity for patients with CF is needed in order for exercise and physical activity to be incorporated as key components of clinical practice and into the lives of patients with CF.

1 Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, Canada

2 Physiology and Experimental Medicine, The Hospital for Sick Children, Toronto, Canada

3 Department of Anaesthesia, The University of Toronto, Toronto, Canada

4 Graduate Department of Exercise Sciences, The University of Toronto, Labatt Family Heart Centre, Hospital for Sick Children, Canada

Corresponding Author InformationCorresponding author. Division of Respiratory Medicine, Rm. 4534, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. Tel: +1 416 710 4618; Fax: +1 416 813 5109.

PII: S1526-0542(09)00039-6

doi:10.1016/j.prrv.2009.04.001


View previous. 5 of 12 View next.

Advertisement